It is suggested that central inflammation may impair the functioning of leptin receptors expressed in the brain, resulting in leptin resistance that blunts its anorexigenic effect and consequently disinhibits feeding despite increasing circulating leptin (a process comparable with insulin resistance in type 2 diabetes)38,51. This evidence concerns the gene LEP and type 2 diabetes mellitus.